immunotherapy
-
healthNHS Rolls Out 1-Minute Immunotherapy Jab for Cancer Patients
A rapid pembrolizumab injection cuts treatment time by 90%, benefiting thousands with 14 cancer types on the NHS.
-
healthImmunotherapy Trial Shows No Cancer Recurrence After Nearly Three Years
A small bowel cancer trial shows pembrolizumab wiped out tumors in 59% of patients. After nearly three years, no recurrence.
-
healthNew HER-2 Vaccine Proves Effective Alongside Antibody Therapy
Investigational HER-2 vaccine ES2B-C001 shows sustained immunogenicity and therapeutic efficacy, even when combined with monoclonal antibody treatments for HER-2-positive disease.
-
healthImmunotherapy Advances in Urothelial Bladder Cancer Treatment
Exploring how immunotherapy harnesses the immune system to fight urothelial bladder cancer, with key treatment types and breakthroughs.
-
healthImmunotherapy Revolutionizes Bladder Cancer Treatment
An overview of how immunotherapy is used to treat urothelial bladder cancer, the most common bladder cancer type in the U.S.
-
healthBlood Pressure Drug May Boost Cancer Treatment Effectiveness
A common blood pressure medication shows promise in enhancing cancer therapies, particularly in combination with PARP inhibitors.
-
healthNew Immune Markers Could Predict Melanoma Aggression and Treatment Response
Scientists identify three immune-related genes, LAG-3, TIGIT, and HAVCR2, that may predict melanoma progression and patient response to immunotherapy.
-
healthHead and Neck Cancer: Immunotherapy and Oncolytic Viruses Reshape Treatment
Explore the cutting edge of head and neck cancer treatment, focusing on immunotherapy and oncolytic viruses, with insights from leading oncologist Kevin Harrington.